Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2025-12-25 @ 4:04 PM
NCT ID:
NCT02065557
Group ID:
EG006
Title:
Integrated Study (Main + Japan Sub- Study): Any Adalimumab
Description:
Participants receiving any adalimumab during Induction or Maintenance Phase.
Any Adalimumab TEAEs: events with an onset date on or after first dose date of adalimumab and up to 70 days after the last dose date of adalimumab and prior to the first dose date in M10-870 if applicable, whichever comes first. For participants who received placebo during the maintenance period, TEAE collection period ends 70 days after last induction dose of adalimumab and re-starts with their next adalimumab dose, if applicable. Mean duration of treatment was 256.3 days.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
22
Serious Number At Risk:
101
Other Number Affected:
65
Other Number At Risk:
101
Study:
NCT02065557
Results Section:
NCT02065557
Adverse Events Module:
NCT02065557